CD4+ CD25+ regulatory T cells approach the clinic

Cytotherapy

Volumn 10, Issue 7, 2008, Pages 655-656

  Edinger, M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

ALLOGENEIC STEM CELL TRANSPLANTATION; AUTOIMMUNITY; CD4+ CD25+ T LYMPHOCYTE; CELL THERAPY; CELL TRANSFER; GOOD MANUFACTURING PRACTICE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKAPHERESIS; LEUKOPENIA; LYMPHOCYTE ACTIVATION; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; T CELL DEPLETION; ULCERATIVE COLITIS;

EID: 56049104936     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240802492705     Document Type: Note

References (15)

1. Sakaguchi, S., Sakaguchi, N. Asano, M. et al. (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol, 155, pp. 1151-1164.
2. Bennett, CL, Christie, J. Ramsdell, F. et al. (2001) The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet, 27, pp. 20-21.
3. Brunkow, ME, Jeffery, EW Hjerrild, KA et al. (2001) Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet, 27, pp. 68-73.
4. + regulatory T cells. Nat Immunol, 4, pp. 330-336.
5. Hori, S., Nomura, T. and Sakaguchi, S. (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science, 299, pp. 1057-1061.
6. + T regulatory cells. Nat Immunol, 4, pp. 337-342.
7. + regulatory T cells. J Immunol, 170, pp. 3939-3943.
8. high regulatory T Cells from leukapheresis products from ulcerative colitis patients, applicable to regulatory T-Cell transfer therapy. Cytotherapy, 10, pp. 698-710.
9. Hoffmann, P., Boeld, TJ Eder, R. et al. (2006) Isolation of CD4(+)CD25(+) regulatory T cells for clinical trials. Biol Blood Marrow Transplant, 12, pp. 267-274.
10. + regulatory T cells and graft-versus-host disease. Semin Hematol, 43, pp. 62-69.
11. high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion. Blood, 108, pp. 4260-4267.
12. Seddiki, N., Santner-Nanan, B. Martinson, J. et al. (2006) Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med, 203, pp. 1693-1700.
13. + T reg cells. J Exp Med, 203, pp. 1701-1711.
14. Sands, BE, Sandborn, WJ Feagan, B. et al. (2008) A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis. Gastroenterology, 135, pp. 400-409.
15. Hanai, H. (2006) Positions of selective leukocytapheresis in the medical therapy of ulcerative colitis. World J Gastroenterol, 12, pp. 7568-7577.